NYSE:BSXBoston Scientific Stock Price, Forecast & News

Boston Scientific's stock was trading at $33.86 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BSX shares have increased by 1.7% and is now trading at $34.44. View which stocks have been most impacted by Coronavirus.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 2 hold ratings, 19 buy ratings and 3 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Boston Scientific.

Boston Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Boston Scientific.

Boston Scientific will be holding an earnings conference call on Wednesday, July 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Boston Scientific Co. (NYSE:BSX) posted its earnings results on Wednesday, April, 29th. The medical equipment provider reported $0.28 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.33 by $0.05. The medical equipment provider had revenue of $2.54 billion for the quarter, compared to analysts' expectations of $2.54 billion. Boston Scientific had a return on equity of 18.24% and a net margin of 39.75%. The firm's quarterly revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.35 EPS. View Boston Scientific's earnings history.

24 analysts have issued 12 month price targets for Boston Scientific's stock. Their forecasts range from $25.00 to $58.00. On average, they expect Boston Scientific's stock price to reach $44.65 in the next twelve months. This suggests a possible upside of 29.7% from the stock's current price. View analysts' price targets for Boston Scientific.

Media headlines about BSX stock have trended very negative on Monday, InfoTrie reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Boston Scientific earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Boston Scientific.

Some companies that are related to Boston Scientific include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Stryker (SYK), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Insulet (PODD), Steris (STE) and Masimo (MASI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include Alibaba Group (BABA), NVIDIA (NVDA), Walt Disney (DIS), Bank of America (BAC), CVS Health (CVS), salesforce.com (CRM), Johnson & Johnson (JNJ), AT&T (T), Home Depot (HD) and Visa (V).

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Boston Scientific's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Factory Mutual Insurance Co. (0.09%), Envestnet Asset Management Inc. (0.05%), Robecosam AG (0.05%), Manning & Napier Group LLC (0.03%), DNB Asset Management AS (0.03%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Edward F Mackey, Eric Francis Yves Thepaut, Halliday Hamish, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, John E Sununu, Joseph Michael Fitzgerald, Kevin J Ballinger, Maulik Nanavaty, Michael F Mahoney, Wendy Carruthers, Williamson Scott, Xin Warren Wang and Yoshiaki Fujimori. View institutional ownership trends for Boston Scientific.

BSX stock was sold by a variety of institutional investors in the last quarter, including Robecosam AG, IFM Investors Pty Ltd, State of Alaska Department of Revenue, Paragon Advisors LLC, Aua Capital Management LLC, Exane Derivatives, and Whittier Trust Co.. Company insiders that have sold Boston Scientific company stock in the last year include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Eric Francis Yves Thepaut, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, and Wendy Carruthers. View insider buying and selling activity for Boston Scientific.

BSX stock was purchased by a variety of institutional investors in the last quarter, including Factory Mutual Insurance Co., Envestnet Asset Management Inc., First American Trust FSB, Gradient Investments LLC, Fulton Bank N. A., Platte River Wealth Advisors LLC, Manning & Napier Group LLC, and Mount Yale Investment Advisors LLC. Company insiders that have bought Boston Scientific stock in the last two years include John E Sununu, and Williamson Scott. View insider buying and selling activity for Boston Scientific.

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BSX stock can currently be purchased for approximately $34.44.

Boston Scientific has a market capitalization of $48.19 billion and generates $10.74 billion in revenue each year. The medical equipment provider earns $4.70 billion in net income (profit) each year or $1.58 on an earnings per share basis. Boston Scientific employs 36,000 workers across the globe.

The official website for Boston Scientific is www.bostonscientific.com.

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-683-4000 or via email at [email protected]